Skip to main content
OpenTrials

Clinical trial condition

Crohn Disease

Explore clinical trials studying Crohn Disease. Study availability and eligibility vary by location and protocol.

1,304 public trials 275 recruiting studies
Refine in advanced search Browse all conditions

Crohn Disease trial results

Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

NCT07483073

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 71 locations
View Trial Details
Recruiting

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

NCT07483099

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 71 locations
View Trial Details
Recruiting

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

NCT06997965

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • Digestive & Liver Center of Florida Orlando, Florida, United States
  • Velocity Clinical- Salt Lake City Salt Lake City, Utah, United States
  • GI Institute Research Foundation Vancouver, British Columbia, Canada
  • London Digestive Disease Institute London, Ontario, Canada
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT06430801

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Digestive Health Specialists ( Site 5064) Dothan, Alabama, United States
  • Arizona Arthritis & Rheumatology Research, PC ( Site 5094) Phoenix, Arizona, United States
  • GI Alliance - Sun City ( Site 5118) Sun City, Arizona, United States
  • University of Arizona Clinical and Translational Sciences Research Center ( Site 5111) Tucson, Arizona, United States
View all 499 locations
View Trial Details
Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

NCT07245394

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +10 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • MA MacMillan Fredericton, New Brunswick, Canada
  • Hamilton Health Sciences Corporation Hamilton, Ontaio, Canada
  • Barrie GI Associates Barrie, Ontario, Canada
View Trial Details

Related conditions